» Articles » PMID: 36200046

Expression of Vimentin Alters Cell Mechanics, Cell-cell Adhesion, and Gene Expression Profiles Suggesting the Induction of a Hybrid EMT in Human Mammary Epithelial Cells

Abstract

Vimentin is a Type III intermediate filament (VIF) cytoskeletal protein that regulates the mechanical and migratory behavior of cells. Its expression is considered to be a marker for the epithelial to mesenchymal transition (EMT) that takes place in tumor metastasis. However, the molecular mechanisms regulated by the expression of vimentin in the EMT remain largely unexplored. We created MCF7 epithelial cell lines expressing vimentin from a cumate-inducible promoter to address this question. When vimentin expression was induced in these cells, extensive cytoplasmic VIF networks were assembled accompanied by changes in the organization of the endogenous keratin intermediate filament networks and disruption of desmosomes. Significant reductions in intercellular forces by the cells expressing VIFs were measured by quantitative monolayer traction force and stress microscopy. In contrast, laser trapping micro-rheology revealed that the cytoplasm of MCF7 cells expressing VIFs was stiffer than the uninduced cells. Vimentin expression activated transcription of genes involved in pathways responsible for cell migration and locomotion. Importantly, the EMT related transcription factor was upregulated only in wild type vimentin expressing cells and not in cells expressing a mutant non-polymerized form of vimentin, which only formed unit length filaments (ULF). Taken together, our results suggest that vimentin expression induces a hybrid EMT correlated with the upregulation of genes involved in cell migration.

Citing Articles

The Cancer Chimera: Impact of Vimentin and Cytokeratin Co-Expression in Hybrid Epithelial/Mesenchymal Cancer Cells on Tumor Plasticity and Metastasis.

Kuburich N, Kiselka J, den Hollander P, Karam A, Mani S Cancers (Basel). 2025; 16(24.

PMID: 39766058 PMC: 11674825. DOI: 10.3390/cancers16244158.


Efficient protocol for isolating human fibroblast from primary skin cell cultures: application to keloid, hypertrophic scar, and normal skin biopsies.

Ningsih S, Jusman S, Syaidah R, Nauli R, Fadilah F Biol Methods Protoc. 2024; 9(1):bpae082.

PMID: 39554256 PMC: 11565194. DOI: 10.1093/biomethods/bpae082.


Vimentin filaments integrate low-complexity domains in a complex helical structure.

Eibauer M, Weber M, Kronenberg-Tenga R, Beales C, Boujemaa-Paterski R, Turgay Y Nat Struct Mol Biol. 2024; 31(6):939-949.

PMID: 38632361 PMC: 11189308. DOI: 10.1038/s41594-024-01261-2.


A fusion protein of vimentin with Fc fragment inhibits Japanese encephalitis virus replication.

Zhang T, Chen Z, Xie L, Xu R, Chen L, Jia T Front Vet Sci. 2024; 11:1368725.

PMID: 38500602 PMC: 10944967. DOI: 10.3389/fvets.2024.1368725.


Environmental stiffness restores mechanical homeostasis in vimentin-depleted cells.

Grolleman J, van Engeland N, Raza M, Azimi S, Conte V, Sahlgren C Sci Rep. 2023; 13(1):18374.

PMID: 37884575 PMC: 10603057. DOI: 10.1038/s41598-023-44835-8.


References
1.
Venkatesh S, Yin M, Glockner J, Takahashi N, Araoz P, Talwalkar J . MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol. 2008; 190(6):1534-40. PMC: 2894569. DOI: 10.2214/AJR.07.3123. View

2.
Green K, Geiger B, Jones J, Talian J, Goldman R . The relationship between intermediate filaments and microfilaments before and during the formation of desmosomes and adherens-type junctions in mouse epidermal keratinocytes. J Cell Biol. 1987; 104(5):1389-402. PMC: 2114486. DOI: 10.1083/jcb.104.5.1389. View

3.
Monzo P, Crestani M, Chong Y, Ghisleni A, Hennig K, Li Q . Adaptive mechanoproperties mediated by the formin FMN1 characterize glioblastoma fitness for invasion. Dev Cell. 2021; 56(20):2841-2855.e8. DOI: 10.1016/j.devcel.2021.09.007. View

4.
Lowery J, Kuczmarski E, Herrmann H, Goldman R . Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function. J Biol Chem. 2015; 290(28):17145-53. PMC: 4498054. DOI: 10.1074/jbc.R115.640359. View

5.
Weiss M, Abel E, Mayberry M, Basile K, Berger A, Aplin A . TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells. Cancer Res. 2012; 72(24):6382-92. PMC: 3531871. DOI: 10.1158/0008-5472.CAN-12-1033. View